New York, NY, United States of America

Steven Nye



Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1997-2001

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Steven Nye

Introduction

Steven Nye is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of protein kinases, holding a total of 7 patents. His work focuses on the development of novel methods and compounds that have the potential to impact various medical conditions.

Latest Patents

One of Steven Nye's latest patents involves the ERK3 MAP2 protein kinase. This invention relates to a newly identified family of protein serine/threonine kinases that phosphorylate microtubule-associated protein 2 (MAP2). The invention is based on the cloning and characterization of novel MAP2 kinases designated extracellular signal-regulated kinase 1, 2, and 3 (ERK1, ERK2, ERK3), which are expressed in the central nervous system. Additionally, it identifies another ERK family member, ERK4, using antisera. The invention provides recombinant nucleic acid molecules and proteins representing members of the MAP2 kinase family, as well as microorganisms, transgenic animals, and cell lines comprising recombinant MAP2 kinase molecules. Furthermore, it offers methods for assaying cellular factor activity, including nerve growth factor activity, where the activation of MAP2 kinase serves as an indicator. These methods may be extremely useful in screening compounds for desired cellular factor activity, particularly in identifying compounds that may be beneficial in treating Alzheimer's disease, peripheral neuropathies, and diabetes.

Career Highlights

Throughout his career, Steven Nye has worked with notable companies, including Regeneron Pharmaceuticals, Inc. His experience in the biotechnology sector has allowed him to contribute to groundbreaking research and development in the field of protein kinases.

Collaborations

Steven has collaborated with esteemed colleagues such as Teri G Boulton and Melanie H Cobb. Their combined expertise has further advanced the research and applications of protein kinases.

Conclusion

Steven Nye's innovative work in the field of protein kinases has the potential to lead to significant advancements in medical treatments. His contributions continue to shape the landscape of biotechnology and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…